Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2

<table>Comparison between SVR rate in patients with high serum TC levels (≥177 mg/dL) and patients with low serum TC levels (&lt;177 mg/dL) in HCV genotype 2 patients.</table>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2 

Figure 1 | Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2 